The Journal of Urology
Volume 184, Issue 2 , Pages 419-422 , August 2010

Treatment of the 2 to 3 cm Renal Mass

  • Monish Aron

      Affiliations

    • Center for Robotic Surgery & Advanced Laparoscopy, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California
    • ,
  • Inderbir S. Gill

      Affiliations

    • Center for Robotic Surgery & Advanced Laparoscopy, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California
    • ,
  • Stephen A. Boorjian

      Affiliations

    • Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania
    • ,
  • Robert G. Uzzo

      Affiliations

    • Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

References 

  1. Gill IS, Aron M, Gervais DA, et al. Clinical practice (Small renal mass). N Engl J Med. 2010;362:624
  2. Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425
  3. Nguyen MM, Gill IS. Effect of renal cancer tumor size on the prevalence of metastasis at diagnosis and mortality. J Urol. 2009;181:1020
  4. Crispen PL, Wong Y-N, Greenberg RE, et al. Predicting growth of solid renal masses under active surveillance. Urol Oncol Semin. 2008;26:555
  5. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217
  6. Kunkle DA, Crispen PL, Li T, et al. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol. 2007;177:1692
  7. Kunkle DA, Crispen PL, Chen DYT, et al. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849
  8. Crispen PL, Viterbo R, Boorjian SA, et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active aurveillance. Cancer. 2009;115:2844
  9. Rybicki FJ, Shu KM, Cibas ES, et al. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol. 2003;180:1281
  10. Gill IS, Kamoi K, Aron M, et al. 800 Laparoscopic partial nephrectomies: a single surgeon series. J Urol. 2010;183:34
  11. Aron M, Kamoi K, Remer E, et al. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol. 2010;183:889
  12. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331
  13. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate, or observe: the small renal mass dilemma-a meta-analysis and review. J Urol. 2008;179:1227
  14. Lane BR, Babineau D, Kattan MW, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178:429
  15. Rothman J, Egleston B, Wong YN, et al. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol. 2009;181:29
  16. Jewett MA, Zuniga A. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am. 2008;35:627
  17. Crispen PL, Viterbo R, Fox EB, et al. Delayed intervention of sporadic renal masses under active surveillance. Cancer. 2008;112:1051
  18. Kutikov A, Egleston BL, Wong YN, et al. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. 2009;28:311

PII: S0022-5347(10)03587-1

doi: 10.1016/j.juro.2010.05.050

The Journal of Urology
Volume 184, Issue 2 , Pages 419-422 , August 2010

Article Tools